Hasil Pencarian (1)
small molecule | CAS: 1825352-65-5
Risdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA).[L12615] It increases systemic SMN protein concentrations by improving the efficiency of _SMN2_ gene transcription. This mechanism of action is …
Kategori:
BCRP/ABCG2 SubstratesCytochrome P-450 CYP3A SubstratesCytochrome P-450 CYP3A4 Substrates
+11
Waktu ParuhThe terminal elimin…
Vol. DistribusiFollowing oral admi…
KlirensFor a 14.9kg patien…
Genetik
-